12:00 AM
 | 
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

CroTAb rattlesnake antivenom regulatory update

PTI said that the FDA has requested supplemental data to validate the manufacturing process for CroTAb to support the company's ELA for the...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >